| 000 | 00809nam a22002537a 4500 | ||
|---|---|---|---|
| 001 | D0001B004518 | ||
| 003 | DOH | ||
| 005 | 20210129141112.0 | ||
| 008 | 210129b ||||| |||| 00| 0 eng d | ||
| 040 | _erda | ||
| 110 | 2 | _aWorld Health Organization | |
| 245 | 0 | 0 |
_aMeasuring transparency in the public pharmaceutical sector : _bassessment instrument |
| 260 |
_aGeneva : _bWHO, _c2009. |
||
| 300 | _a185 pages. | ||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarier _avolume |
||
| 650 | 2 | _aPharmaceutical Preparations | |
| 650 | 2 | _aDrug Industry | |
| 650 | 2 | _aEthics | |
| 650 | 2 |
_aDrugs, Essential _xsupply and distribution |
|
| 856 | _uhttps://apps.who.int/iris/bitstream/handle/10665/112681/WHO_EMP_MAR_2009.4_eng.pdf?sequence=1&isAllowed=y | ||
| 942 |
_2nlm _cBK |
||
| 999 |
_c2604 _d2604 |
||